SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Acceleron Pharma Inc. Buyout
WILMINGTON, Del., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Acceleron Pharma Inc. (“Acceleron”) (NASDAQ GM: XLRN ) regarding possible breaches of fiduciary duties and other violations of law related to Acceleron’s agreement to be acquired by Merck & Co. Under the terms of the agreement, Acceleron’s shareholders will receive $180 in cash for each share of Acceleron common stock they own.
To learn more about this investigation and your rights, visit https://www.rl-legal.com/cases-acceleron-pharma-inc.
You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or email@example.com.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.